- The main pillars of safe immunotherapy2021 | Faculty of Medicine in Pilsen
- Mechanisms of resistance to melanoma immunotherapy2023 | First Faculty of Medicine
- Renal cell carcinoma - current practice in 20192020 | First Faculty of Medicine
- Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story2019 | Third Faculty of Medicine
- Mechanisms of resistance in malignant melanoma treated by targeted therapy2020 | First Faculty of Medicine
- Advances in management of stage III non-small cell lung cancer2022 | First Faculty of Medicine
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University
- What brings modern therapy to advanced non small cell lung cancer2017 | Faculty of Medicine in Pilsen
- Actual immunotherapeutic options in pneumooncology2021 | Third Faculty of Medicine
- Immunotherapy of triple negative breast cancer2019 | Faculty of Physical Education and Sport, First Faculty of Medicine, Central Library of Charles University
- Current treatment options for metastatic castration-resistant prostate cancer2018 | Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- News in the systemic treatment of advanced kidney cancer2016 | Publication without faculty affiliation
- Supportive treatment in oncology - several interesting topics2022 | Faculty of Medicine in Pilsen
- Differential diagnosis of pituitary enlargement2022 | First Faculty of Medicine
- Immunotherapy in squamous NSCLC - nivolumab clinical data, our experiences with nivolumab treatment2018 | Faculty of Medicine in Pilsen
- New methodology of TMB assessment from tissue and liquid biopsy in NSCLC2022 | First Faculty of Medicine